We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
Guidance on the submission and content of notifications for Northern Ireland
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
Sets out the process for pharmaceutical companies to appeal against decisions made by the Secretary of State for Health and Social Care.
Expansion of extra-jurisdictional inspection outcomes.
General advice on vigilance - electronic cigarettes devices and refill containers.
How to test and report levels of nicotine uptake when submitting a notification of intent to market e-cigarette and vape products.
Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.
£500k is available to fund the development of novel PoC diagnostics devices.
Guidance on moving medicines by air
Deficiencies in Omega’s pharmacovigilance system are not thought to affect the safety of the products that they market.
To celebrate International Women’s Day 2023, some of our colleagues have shared their passion for STEM.
We can provide access to world-class regulatory knowledge, expertise and experience from within the MHRA.
Interventions that can be made by pharmacy teams, to improve quality of life for older people.
Guidance for health professionals on dealing with Listeriosis in relation to Sainsbury’s national recall of products on 26 June 2017.
The findings and recommendations of the Expert Advisory Group on paclitaxel drug-coated balloon catheters and drug-eluting stents which are used to treat patients with peripheral arterial disease.
For manufacturers reporting adverse incidents with neurostimulators under the vigilance system.
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).